Home
Applications
- Indications
Business
Technology
Investors
News
About Us
Contact Us

OBD launches major Diabetes epigenetics programme in Malaysia to ascertain who is at risk for Type 2 Diabetes.

April 21, 2016

|By Catia Gaspar

Check out the news in The Diabetes Research & Wellness Foundation

Recent Posts

Collaboration agreement with Casa Sollievo della Sofferenza signed for the blood-based diagnosis of Autism Spectrum Disorder
Epigenetic chromatin conformation changes in peripheral blood can detect thyroid cancer.
Fifth collaboration agreement signed in immuno-oncology space
Genomic architecture differences at the HTT locus underlie symptomatic and pre-symptomatic cases of Huntington’s disease.
Study published in Faculty of 1000 Research identifies epigenetic changes for monitoring disease progression in Huntington’s disease (HD)

Archives

Categories

Episwitch Publication
Events
Milestones
People
Publications
Uncategorized

Meta

Log in
Entries RSS
Comments RSS
WordPress.org

Prev
Next

Terms of Use
Site Map

Privacy Policy
Cookies Policy

Regulated and Licensed by Human Tissue Authority
License No. 12571

© 2002-2018 Oxford Biodynamics Plc

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.Ok Read more